Evidence map›Paper›PMID 37663000›Full record

ArticleMethodsX2023

Translation and cross-cultural adaptation of EAT-26 questionnaire in Urdu.

Anam Jamil, Nida Zahid, Momina Imtiaz, Hadia Binte Obaid, Asma Muhammad, Aniqa Jamil

Abstract read
In one paragraph

Article in MethodsX, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anam JamilDepartment of Rehabilitation Sciences, Shifa Tameer e Millat University, Park road, Islamabad, Pakistan.
Nida ZahidPrimal Support, E 11/4, Islamabad, Pakistan.
Momina ImtiazDepartment of Rehabilitation Sciences, Shifa Tameer e Millat University, Park road, Islamabad, Pakistan.
Hadia Binte ObaidDepartment of Rehabilitation Sciences, Shifa Tameer e Millat University, Park road, Islamabad, Pakistan.
Asma MuhammadDepartment of Rehabilitation Sciences, Shifa Tameer e Millat University, Park road, Islamabad, Pakistan.
Aniqa JamilHuman Development Research Foundation, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EAT-26 questionnaire is used globally to screen people for the risk of eating disorders. In addition to this, the EAT-26 is being used in its original English version in research and clinical settings due to unavailability of the Urdu version. Therefore, the aim of this study was to introduce the Urdu version of EAT-26 to clinicians and academicians in Pakistan, interested in the assessment of population at risk of eating disorders. After getting the formal permission for translation by Dr. D. M. Garner, WHO guidelines were followed for the translation and adaptation process. Two independent translators with psychological background worked under the supervision of a lead to produce the definitive version following six steps of translation and adaptation. Cognitive interviews and focused group discussions helped in the assessment process for the understanding level of translated Urdu version. The pre-final version showed comprehension and acceptability during initial pilot testing.•The final translated version of EAT-26 in Urdu will be available on Internet to use. It is expected that the use of EAT-26 will be widespread in Pakistan, aiming at the assessment of eating disorders.•The Urdu version of EAT-26 is finalized, and ready to use by researchers and clinicians in Pakistan.

Indexed as

Cultural adaptationEAT-26 questionnaireEating disorderstranslationTranslation and cross-cultural adaptation in Urdu

Identifiers

PMID37663000
PMCPMC10472286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.